OpenLegislation

Regulation 51 Patient choice: pharmaceutical servicesF7

England and Wales

(1)

A contractor authorised to use the Electronic Prescription Service for its patients must F1, if a patient, or where appropriate the patient’s authorised person, so requests, enter into the particulars relating to the patient which are held in the Patient Demographic Service operated by F2NHS EnglandM1—

(a)

where the patient does not have a nominated dispenser, the dispenser chosen by the patient F3or where appropriate the patient’s authorised person;

(b)

where the patient does have a nominated dispenser—

(i)

a replacement dispenser, or

(ii)

a further dispenser,

chosen by the patient.

(2)

Paragraph (1)(b)(ii) does not apply if the number of the nominated dispensers would thereby exceed the maximum number permitted by the Electronic Prescription Service.

F4(2A)

The contractor must, where the patient has nominated a dispenser, consult the patient, or the patient’s authorised person, as to their choice of dispenser in respect of each order for drugs, medicines or appliances made by a prescriber under regulation 49.

F5(3)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F6(4)

A contractor must not seek to persuade a patient, or a patient’s authorised person, to nominate a dispenser recommended by the prescriber or the contractor.

(5)

The contractor must direct the patient, or the patient’s authorised person, to the relevant information made available by NHS England about all chemists who are available in the patient’s chosen area and who are able to provide the required service where—

(a)

a patient does not have a nominated dispenser;

(b)

a patient, or a patient’s authorised person, asks the contractor to recommend a chemist whom the patient or the patient’s authorised person might nominate as the patient’s dispenser; or

(c)

the contractor refers a patient to a pharmaceutical service.

Annotations

Textual amendments

F1

Words in reg. 51(1) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 23(2)(a)

F2

Words in reg. 51(1) substituted (1.2.2023) by The Health and Social Care Information Centre (Transfer of Functions, Abolition and Transitional Provisions) Regulations 2023 (S.I. 2023/98), reg. 1(2), Sch. para. 53(4) (with reg. 3)

F3

Words in reg. 51(1)(a) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 23(2)(b)

F4

Reg. 51(2A) inserted (15.6.2026) by The National Health Service (General Medical Services Contracts and Personal Medical Services Agreements) (Amendment) Regulations 2026 (S.I. 2026/532), reg. 1(2), Sch. 2 para. 2(b)

F5

Reg. 51(3) omitted (26.11.2018) by virtue of The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 23(3)

F6

Reg. 51(4)(5) substituted for reg. 51(4) (15.6.2026) by The National Health Service (General Medical Services Contracts and Personal Medical Services Agreements) (Amendment) Regulations 2026 (S.I. 2026/532), reg. 1(2), Sch. 2 para. 2(c)

F7

Reg. 51 heading substituted (15.6.2026) by The National Health Service (General Medical Services Contracts and Personal Medical Services Agreements) (Amendment) Regulations 2026 (S.I. 2026/532), reg. 1(2), Sch. 2 para. 2(a)

Marginal citations

M1

The Health and Social Care Information Centre is a body corporate established by section 252(1) of the Health and Social Care Act 2012 (c.7).